A phase II study for metabolic in vivo response monitoring with sequential 18FDG-PET-CT during treatment with the EGFR-monoclonal-antibody cetuximab in metastatic colorectal cancer: the Heidelberg REMOTUX trial
about
Positron Emission Tomography for the Response Evaluation following Treatment with Chemotherapy in Patients Affected by Colorectal Liver Metastases: A Selected ReviewModification du métabolisme tumoral au cours du traitement : suivi de la réponse thérapeutique par tomographie par émission de positons
P2860
A phase II study for metabolic in vivo response monitoring with sequential 18FDG-PET-CT during treatment with the EGFR-monoclonal-antibody cetuximab in metastatic colorectal cancer: the Heidelberg REMOTUX trial
description
2012 nî lūn-bûn
@nan
2012 թուականի Մարտին հրատարակուած գիտական յօդուած
@hyw
2012 թվականի մարտին հրատարակված գիտական հոդված
@hy
2012年の論文
@ja
2012年論文
@yue
2012年論文
@zh-hant
2012年論文
@zh-hk
2012年論文
@zh-mo
2012年論文
@zh-tw
2012年论文
@wuu
name
A phase II study for metabolic ...... : the Heidelberg REMOTUX trial
@ast
A phase II study for metabolic ...... : the Heidelberg REMOTUX trial
@en
A phase II study for metabolic ...... : the Heidelberg REMOTUX trial
@nl
type
label
A phase II study for metabolic ...... : the Heidelberg REMOTUX trial
@ast
A phase II study for metabolic ...... : the Heidelberg REMOTUX trial
@en
A phase II study for metabolic ...... : the Heidelberg REMOTUX trial
@nl
prefLabel
A phase II study for metabolic ...... : the Heidelberg REMOTUX trial
@ast
A phase II study for metabolic ...... : the Heidelberg REMOTUX trial
@en
A phase II study for metabolic ...... : the Heidelberg REMOTUX trial
@nl
P2093
P2860
P921
P356
P1433
P1476
A phase II study for metabolic ...... : the Heidelberg REMOTUX trial
@en
P2093
Anne Katrin Berger
Annika Stange
Carl von Gall
Dirk Jäger
Florian Lordick
Georg Martin Haag
Jennifer Ose
Matthias Kloor
Tim Frederik Weber
Ulrich Abel
P2860
P2888
P356
10.1186/1471-2407-12-108
P407
P577
2012-03-22T00:00:00Z
P5875
P6179
1006607652